documented is hemopoietic toxicity encountered in patients with primary liver cancer ( plc ) , metastatic breast cancer , and colorectal cancer treated with various anthracyclines ( doxorubicin [ adriamycin , adr ] , 4-'epidoxorubicin [ 4-'epiadr ] , and esorubicin ) or anthracenes ( mitoxantrone and bisantrene , as single agents as well as different combinations ) .
C0013089
doxorubicin
C0014582
4